home · filing · 0001493152-24-021982
8-K filed May 30, 2024, 7:59 PM ET
ticker SMTI
CIK 0000714256
leadership
confidence high
sentiment neutral
materiality 0.70
Sanara MedTech Inc. CEO Zachary B. Fleming Resigns, Enters Separation Agreement
Sanara MedTech Inc.
Zachary B. Fleming resigned as CEO effective May 10, 2024; separation agreement signed May 29, 2024.
Separation benefits include 12 months base salary paid in installments over 12 months.
Company to pay COBRA premiums for Fleming and dependents during the severance period.
50% of unvested restricted stock continues to vest; partial acceleration for tax withholding.
Fleming provides general release and non-disparagement covenant in exchange for benefits.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Zachary B. Fleming
Chief Executive Officer
SMTI ·
Sanara MedTech Inc.
Effective 2024-05-10
Filed May 30, 2024, 7:59 PM ET
Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Zachary B. Fleming resigned as Chief Executive Officer at Sanara MedTech Inc..
Action resigned
Role Chief Executive Officer
Exact text from the filing
Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-021982
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.